These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8018099)

  • 1. Mutagenicity study of the new cognition-enhancing agent nefiracetam.
    Shimada H; Hattori C; Tanaka N; Takayama S
    Arzneimittelforschung; 1994 Feb; 44(2A):251-3. PubMed ID: 8018099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single dose toxicity study of the new cognition-enhancing agent nefiracetam in mice, rats and dogs.
    Sugawara T; Kato M; Furuhama K; Inage F; Suzuki N; Takayama S
    Arzneimittelforschung; 1994 Feb; 44(2A):211-3. PubMed ID: 8018091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenicity studies of the cognition-enhancing agent nefiracetam in mice and rats.
    Kajimura T; Satoh H; Rajasekaran D; Spicer EJ; Nakashima N; Takayama S
    Arzneimittelforschung; 1994 Feb; 44(2A):254-9. PubMed ID: 8018100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenicity of the new quinolone antibacterial agent levofloxacin.
    Shimada H; Itoh S; Hattori C; Tada S; Matsuura Y
    Arzneimittelforschung; 1992 Mar; 43(3A):378-85. PubMed ID: 1622436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug dependence study of the new cognition-enhancing agent nefiracetam in rats.
    Fujikawa K; Akiyama Y; Takayama S
    Arzneimittelforschung; 1994 Feb; 44(2A):243-7. PubMed ID: 8018097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity studies of benzalazine.
    Herzog R; Leuschner J
    Arzneimittelforschung; 1994 Dec; 44(12):1366-8. PubMed ID: 7848359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thirteen-week oral toxicity study of the new cognition-enhancing agent nefiracetam in rats.
    Jindo T; Shimizu Y; Kato M; Takayama S
    Arzneimittelforschung; 1994 Feb; 44(2A):214-6. PubMed ID: 8018092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenicity study of the new cognition-enhancing agent nefiracetam.
    Wagai N; Yamaguchi F; Hasegawa T; Takayama S
    Arzneimittelforschung; 1994 Feb; 44(2A):247-50. PubMed ID: 8018098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenicity studies of muroctasin.
    Shimada H; Hattori C; Sato T
    Arzneimittelforschung; 1988 Jul; 38(7A):1031-3. PubMed ID: 3056424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thirteen-week oral toxicity study of the new cognition-enhancing agent nefiracetam in dogs.
    Sugawara T; Kato M; Suzuki N; Akahane K; Takayama S
    Arzneimittelforschung; 1994 Feb; 44(2A):217-9. PubMed ID: 8018093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproductive toxicity studies of the new cognition-enhancing agent nefiracetam in rats and rabbits.
    Watanabe T; Matsuhashi K; Shimada M; Harada S; Tawara K; Takayama S
    Arzneimittelforschung; 1994 Feb; 44(2A):239-42. PubMed ID: 8018096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity study of the new cephalosporin antibiotic cefditoren pivoxil.
    Shindo Y; Hayashi H; Ando M; Tatebayashi T
    Arzneimittelforschung; 1996 Aug; 46(8):815-21. PubMed ID: 9125285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro genotoxicity of para-phenylenediamine and its N-monoacetyl or N,N'-diacetyl metabolites.
    Garrigue JL; Ballantyne M; Kumaravel T; Lloyd M; Nohynek GJ; Kirkland D; Toutain H
    Mutat Res; 2006 Sep; 608(1):58-71. PubMed ID: 16807077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic toxicity studies with genistein.
    Michael McClain R; Wolz E; Davidovich A; Bausch J
    Food Chem Toxicol; 2006 Jan; 44(1):42-55. PubMed ID: 16198038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fifty-two-week oral toxicity study of the new cognition-enhancing agent nefiracetam in rats.
    Hooks WN; Colman KA; Gopinath C; Inage F; Kato M; Takayama S
    Arzneimittelforschung; 1994 Feb; 44(2A):220-8. PubMed ID: 8018094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the mutagenicity of 1-hydrazino-4-(3,5-dimethyl-1-pyrazolyl) pyridazino[4,5-b]indole.
    Lopez-de Cerain A; García E; Gullón A; Alvarez T; Losa MJ; Monge A
    Arzneimittelforschung; 1994 Mar; 44(3):310-2. PubMed ID: 8192696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.